Procedures of data merging in precision cancer medicine: the PRIME-ROSE project

Background and purpose: As more interventional clinical trials in Precision Cancer Medicine (PCM) are introduced, molecular descriptions of tumours have led to multiple subtypes, even within common tumour types. Therefore, the main limitation of these trials is the small number of eligible patients...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Henk van der Pol, Tina Kringelbach, Maria Martin Agudo, Gabriel Bratseth Stav, Gro Live Fagereng, Marta Fiocco, Ragnhild Sørum Falk, Victoria Homer, Soemeya Haj Mohammad, Hans Timmer, Loic Verlingue, Åslaug Helland, Kristoffer Rohrberg, Ulrik Lassen, Sarah Halford, Katriina Jalkanen, Tanja Juslin, Matthew G Krebs, Julio Oliveira, Edita Baltruskeviciene, Kristiina Ojamaa, Kjetil Taskén, Hans Gelderblom
Format:	Artigo
Sprog:	Inglês
Udgivet:	Medical Journals Sweden 2026-01-01
Serier:	Acta Oncologica
Fag:	Data sharing DRUP-like clinical trials (DLCTs) European project Precision Cancer Medicine (PCM) inclusion rate
Online adgang:	https://medicaljournalssweden.se/actaoncologica/article/view/44889
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!